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Supplementary Figure 4A: Scheme of the lentiviral vectors, as integrated proviruses, that have 
been used in this study (not drawn to scale). SIN-LTR, self-inactivating-long-terminal repeat; Ψ, 
packaging signal; RRE, rev-responsive element; cPPT, central polypurine tract; SFFV, Spleen 
focus-forming virus enhancer/promoter; human Wt-p53, cDNA coding for human wild-type p53; 
IRES, internal ribosome entry site of the Encephalo myocarditis virus; eGFP (enhanced green 
fluorescent protein), a green fluorescent protein; 2A, self cleaving peptide of Porcine Teschovirus-1 
(P2A); PuroR-opt, codon optimized cDNA of puromycin resistance (PAC, puromycin N-acetyl-
transferase); wPRE, Woodchuck hepatitis virus post-transcriptional regulatory element. 
 
 
 Supplementary Figure 4B: UKF-NB-3rNUTLIN10µM cells (A + B), UKF-NB-3rNutlin10µM cells 
transduced with LeGO-iG2-Puro+-p53 (UKF-NB-3rNUTLIN10µMwtp53) (C + D) and UKF-NB-














F)   UKF-NB-3rNUTLIN10µMcontrol 
 
 
photographed by inverse light microscopy (A, C, E) and by fluorescence microscopy (B, D, F), 
using an IX71 fluorescence microscope (Olympus, Hamburg, Germany). Fluorescence dye eGFP 
(enhanced green fluorescent protein) was detected at 484/507nm (excitation/emission). The non-
transduced control cell line UKF-NB-3rNUTLIN10µM showed no fluorescence (B). In contrast, UKF-
NB-3rNUTLIN10µMwtp53 and UKF-NB-3rNUTLIN10µMcontrol cells displayed high fluorescence due to 


















                                         
      
 
Supplementary Figure 4C: Western Blot was carried out with UKF-NB-3, UKF-NB-3rNUTLIN10µM, 
UKF-NB-3rNUTLIN10µMcontrol, or UKF-NB-3rNUTLIN10µMwtp53 cells, detecting p53 (Alexis Biochemicals 








MATERIAL AND METHODS 
 
Cloning of lentiviral vectors. Standard molecular cloning techniques were used to 
generate viral vectors based on Lentiviral Gene Ontology (LeGO) vectors [1, also 
http://www.LentiGO-Vectors.de]. Maps and sequence data of the vectors are available 
upon request. The human p53-cDNA was kindly provided by Eva Lenfert, Department of 
Tumor Virology, Heinrich-Pette-Institute Hamburg. The 1182 bp cDNA coding for human 
p53 gene (sequence identical to Accession No. NM_000546) was cloned by PCR into 
LeGO-iG2-Puro+ using EcoRI and NotI. The sequence of p53 was verified by sequencing. 
The internal SFFV promoter of this vector transcribes a bicistronic mRNA with an internal 
ribosome entry site (IRES) of the Encephalo myocarditis virus (EMCV), expressing human 
wild type p53 together with a dual marker, the enhanced green fluorescent protein (eGFP) 
coupled to a codon optimized puromycin resistance [2] by a P2A sequence.  
The monocistronic vector LeGO-G2-Puro+ expressing eGFP and puromycin resistance 
coupled by a P2A sequence served as a control. 
 
Generation of viral particles. Cell-free viral supernatants were generated by transient 
transfection of 293T packaging cells as described [1], using the 3rd generation packaging 
plasmids pMDLg/pRRE and pRSV-Rev [3] together with phCMV-VSV-G [4]. Supernatants 
containing pseudotyped vector particles were titrated on 293T target cells. Gene transfer 
rates were analysed 2 days after transduction by fluorescence activated cell scanning 
(FACS). Titres of 1 x107 (LeGO-iG2-Puro+-p53) and 2,5 x107 (LeGO-G2-Puro+) VSV-G 
pseudotyped vector particles per millilitre unconcentrated supernatants were obtained. 
 
Cell culture and lentiviral gene transfer. All cells were cultured in their respective growth 
media supplemented with penicillin/streptomycin. For transduction of UKF-NB-3rNUTLIN10 
target cells, 5x104 cells in 500µl medium were plated per well in a 24-well plate. The next 
day, 100µl and 250µl of viral supernatant per well were added and incubated for 3 days. 
 
Fluorescence Microscopy. Pictures were taken using an IX71 fluorescence microscope 
(Olympus, Hamburg, Germany). Fluorescence dye eGFP was detected at 484/507nm 
(excitation/emission) 
 
Western Blot. Cells were lysed in Triton X sample buffer and separated by SDS-PAGE, as 
described before [5]. Proteins were detected using specific antibodies against β-actin 
(Sigma, Munich, Germany) or p53 (Alexis Biochemicals via AXXORA Deutschland, 
Lörrach, Germany), and were visualized by enhanced chemiluminescence using a 
commercially available kit (Amersham via GE Healthcare, Munich, Germany). 
 
Viability assay. Cell viability was tested by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) dye reduction assay after 96 h incubation, modified as 
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